Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 7/20 | 0.41 |
| ▸ | CDK2 | P24941 | 7/20 | 0.41 |
| ▸ | GSK3B | P49841 | 5/20 | 0.41 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.34 |
| ▸ | RIOK2 | Q9BVS4 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953405 | 0.87 | CYP3A4 (0.40) | CCNE1CDK2GSK3BAAK1IGF1R | |
| SCHEMBL30953409 | 0.87 | CYP3A4 (0.40) | CCNE1CDK2GSK3BAAK1IGF1R | |
| SCHEMBL30953236 | 0.84 | CDK5 (0.40) | AAK1IGF1RNR3C2MEN1KMT2A | |
| SCHEMBL30953458 | 0.84 | IGF1R (0.45) | CCNE1CDK2GSK3BIGF1RNR3C2 | |
| SCHEMBL30952958 | 0.82 | IL17A (0.37) | CCNE1CDK2GSK3BNR3C2KMT2A | |
| SCHEMBL30953247 | 0.82 | AAK1 (0.35) | AAK1MEN1KMT2ACYP3A4SCN9A | |
| SCHEMBL30953345 | 0.79 | AAK1 (0.36) | AAK1IGF1RNR3C2MEN1KMT2A | |
| SCHEMBL30953342 | 0.79 | AAK1 (0.38) | AAK1IGF1RNR3C2MEN1KMT2A | |
| SCHEMBL30952986 | 0.77 | IGF1R (0.39) | AAK1IGF1RNR3C2CYP3A4SCN9A | |
| SCHEMBL30953263 | 0.77 | AAK1 (0.39) | GSK3BAAK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |